Hoya and Hitachi Announce Long Term Technical Collaboration to Endoscopic Ultrasound Systems

By AIT News Desk On Jul 6, 2020

HOYA Corporation and Hitachi, Ltd. announced a five year contract regarding Endoscopic Ultrasound Systems [EUS] by which, i) the parties will strengthen technical collaboration, and ii) Hitachi will continue supplying diagnostic ultrasound systems and ultrasound sensor related parts used in EUS.

EUS consists of a diagnostic ultrasound system and ultrasound flexible endoscopes, and is used for examinations to evaluate the cancer staging in the liver, pancreas and bronchus. PENTAX Medical is a division of HOYA Group delivering endo-imaging solutions.

Hitachi’s diagnostic imaging-related business is expected to be transferred to FUJIFILM Corporation, subject to customary closing conditions and regulatory approvals, and this agreement will be valid after such transfer.

NetApp Joins the Vultr Cloud Alliance to Provide Scalable Data Management for Enterprise AI Workloads

Nov 25, 2024

Smodin Unites Powerful Domains to Deliver an All-in-One AI Platform

Nov 25, 2024

Cerebras Appoints Tom Lantzsch to Board of Directors

Nov 25, 2024

Prev Next 1 of 40,383

Gerald Bottero, Global President of Pentax Medical, HOYA Corporation, stated, “We are honored to continue our alliance with Hitachi which began with joint research in 1983 leading to the first commercial launch of our EUS in 1990. The Hitachi ultrasound technology is globally recognized as an important standard in EUS with high-quality imaging, advanced software modalities, and ease of use. We look forward to working with Hitachi’s world-class research teams to accelerate innovation and wide adoption in this vital space.”

Toshihiko Kawano, CTO of Healthcare Business Unit, Hitachi, Ltd. said, “It is our pleasure to keep continuing the business relation of EUS with PENTAX Medical Division, HOYA Corporation. Hitachi and PENTAX Medical have been working together for more than 30 years and developing innovative technologies in EUS. We look forward to collaborating in the future and exploring new clinical values to provide for better diagnosis and treatment.”